Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsgenetics-dysmorphology-and-metabolism

Paeds SAQs · genetics-dysmorphology-and-metabolism

Fatty-acid oxidation disorders — formative SAQs

Formative SAQs on recognising the hypoketotic hypoglycaemia signature of a fatty-acid oxidation disorder, delivering the acute intravenous-dextrose protocol, localising the defect with plasma acylcarnitines, and locking in long-term fasting avoidance, an emergency sick-day plan, and disease-specific therapy for long-chain defects.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Fatty-acid oxidation disorders

SAQ 1 (10 marks)

A 14-month-old girl is brought to the emergency department with a two-day history of vomiting and lethargy following a febrile illness. She has not eaten for approximately 14 hours. On arrival she is drowsy, her bedside glucose is 1.8 mmol/L, and a point-of-care ketone measurement returns 0.1 mmol/L. [1] [5]

a) Explain why the combination of a low blood glucose with inappropriately low ketones is the signature of a fatty-acid oxidation disorder, and describe the physiological mechanism that produces this pattern. (3 marks) [1] [5]

b) Outline the immediate resuscitation you perform, including the specific intravenous therapy and why glucagon would be ineffective. (3 marks) [1] [2]

c) Describe the critical sample you collect at the time of hypoglycaemia and the first-tier diagnostic test that will localise the defect. Explain how plasma acylcarnitines would distinguish MCAD deficiency from a long-chain defect. (2 marks) [1]

d) Discuss the long-term management plan, including fasting avoidance, the emergency sick-day plan, and how newborn screening changed the prognosis of this condition. (2 marks) [5] [7]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Merritt JL 2nd, Norris M, Kanungo S. Fatty acid oxidation disorders. Ann Transl Med, 2018.PMID 30740404
  2. [2]Vockley J Long-chain fatty acid oxidation disorders and current management strategies. Am J Manag Care, 2020.PMID 32840329
  3. [5]Wilcken B. Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis, 2010.PMID 20049534
  4. [6]Derks TG, Reijngoud DJ, Waterham HR, et al. The natural history of medium-chain acyl CoA dehydrogenase deficiency in the Netherlands: clinical presentation and outcome. J Pediatr, 2006.PMID 16737882
  5. [7]Wilcken B, Haas M, Joy P, Wiley V, et al. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years. Pediatrics, 2009.PMID 19620191
  6. [9]Vockley J, Burton B, Berry GT, Longo N, et al. Triheptanoin for the treatment of long-chain fatty acid oxidation disorders: Final results of an open-label, long-term extension study. J Inherit Metab Dis, 2023.PMID 37276053
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousEthical issues in genomic diagnosis and cascade testinggenetics-dysmorphology-and-metabolismNextFragile X syndrome — formative SAQsgenetics-dysmorphology-and-metabolism